CXL 017
CXL 017 is a sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor. CXL 017 can inhibit the ATPase activity of SERCA by competing with ATP for binding. CXL 017 exhibits selective cytotoxicity against multidrug-resistant acute myeloid leukemia cells HL60/MX2. CXL 017 can be used in the research of tumors such as multidrug-resistant acute myeloid leukemia.
For research use only. We do not sell to patients.
- CAS No.: 1063714-11-3
- Formula: C24H27NO7
- Molecular Weight:441.47
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Calcium Channel Isoforms
More
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| DU-145 | IC50 |
11.49 μM
Compound: 5q, CXL017
|
Cytotoxicity against human DU145 cells after 48 hrs by cell titer-blue assay
Cytotoxicity against human DU145 cells after 48 hrs by cell titer-blue assay
|
[PMID: 19743858] |
| HCT-116 | IC50 |
8.83 μM
Compound: 5q, CXL017
|
Cytotoxicity against human HCT116 cells after 48 hrs by cell titer-blue assay
Cytotoxicity against human HCT116 cells after 48 hrs by cell titer-blue assay
|
[PMID: 19743858] |
| HL-60 | IC50 |
10.7 μM
Compound: 7c
|
Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay
Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay
|
[PMID: 22582991] |
| HL-60 | IC50 |
5.4 μM
Compound: 1; CXL017
|
Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 48 hrs by cell titer blue cell viability assay
Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 48 hrs by cell titer blue cell viability assay
|
[PMID: 26867486] |
| HL-60 | IC50 |
10100 nM
Compound: 13; CXL017
|
Antiproliferative activity against human HL-60 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay
Antiproliferative activity against human HL-60 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay
|
[PMID: 37690265] |
| HL60/MX2 | IC50 |
1.7 μM
Compound: 1; CXL017
|
Cytotoxicity against human HL60/MX2 cells assessed as cell growth inhibition after 48 hrs by cell titer blue cell viability assay
Cytotoxicity against human HL60/MX2 cells assessed as cell growth inhibition after 48 hrs by cell titer blue cell viability assay
|
[PMID: 26867486] |
| HL60/MX2 | IC50 |
2500 nM
Compound: 13; CXL017
|
Cytotoxicity against human HL60/MX2 assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Cytotoxicity against human HL60/MX2 assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 37690265] |
| Jurkat | IC50 |
1.2 μM
Compound: 5q, CXL017
|
Cytotoxicity against human Jurkat cells after 48 hrs by cell titer-blue assay
Cytotoxicity against human Jurkat cells after 48 hrs by cell titer-blue assay
|
[PMID: 19743858] |
| Jurkat | IC50 |
1200 nM
Compound: 13; CXL017
|
Antiproliferative activity against human Jurkat cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human Jurkat cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 37690265] |
| MCF7 | IC50 |
15.48 μM
Compound: 5q, CXL017
|
Cytotoxicity against human MCF7 cells after 48 hrs by cell titer-blue assay
Cytotoxicity against human MCF7 cells after 48 hrs by cell titer-blue assay
|
[PMID: 19743858] |
| NALM-6 | IC50 |
4.74 μM
Compound: 5q, CXL017
|
Cytotoxicity against human NALM6 cells after 48 hrs by cell titer-blue assay
Cytotoxicity against human NALM6 cells after 48 hrs by cell titer-blue assay
|
[PMID: 19743858] |
| NCI-H460 | IC50 |
5.14 μM
Compound: 5q, CXL017
|
Cytotoxicity against human H460 cells after 48 hrs by cell titer-blue assay
Cytotoxicity against human H460 cells after 48 hrs by cell titer-blue assay
|
[PMID: 19743858] |
| REH | IC50 |
4.16 μM
Compound: 5q, CXL017
|
Cytotoxicity against human REH cells after 48 hrs by cell titer-blue assay
Cytotoxicity against human REH cells after 48 hrs by cell titer-blue assay
|
[PMID: 19743858] |
| SU.86.86 | IC50 |
7.03 μM
Compound: 5q, CXL017
|
Cytotoxicity against human SU-8686 cells after 48 hrs by cell titer-blue assay
Cytotoxicity against human SU-8686 cells after 48 hrs by cell titer-blue assay
|
[PMID: 19743858] |
Chemical Information
-
CAS No. 1063714-11-3
-
Molecular Weight 441.47
-
Formula C24H27NO7
-
SMILES
O=C(C1=C(N)OC2=C(C=C(C3=CC(OC)=CC(OC)=C3)C=C2)C1CC(OCC)=O)OCC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Ca2+ Staining Technique
Ca2+ staining is an experimental technique that utilizes specific fluorescent probes (such as Fluo-4 AM, Fura-2, etc.) to qualitatively or quantitatively detect dynamic changes in intracellular Ca2+ concentrations; this is achieved by monitoring the changes in fluorescent signals generated when these probes bind to free intracellular calcium ions. The underlying principle relies primarily on the presence of chelating groups within the probe's molecular structure that possess high affinity for calcium ions.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)